Literature DB >> 26884824

Relationship between the gene polymorphisms of kallikrein-kinin system and Alzheimer's disease in a Hunan Han Chinese population.

Yanyao Deng1, Deren Hou2, Mi Tian2, Wei Li1, Xialu Feng2, Zhuling Yu2.   

Abstract

This study aimed to determine the connection between polymorphisms of kallikrein kinin system including KLK1 (rs5516), KNG1 (rs710446, rs2304456) and ACE (rs4291, rs4309, rs4343) and late-onset Alzheimer's disease (LOAD). The research was conducted as a case-control study, comprising 201 AD patients in the AD group, and 257 healthy subjects as the control group. PCR amplification and matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (MALDI-TOF MS) were used to detect the six polymorphisms (rs5516 in KLK1; rs710446, rs2304456 in KNG1; rs4291, rs4309, rs4343 in ACE) from both groups. No statistically significant difference was found between the genotype and allelotype distributions of rs5516, rs710446, rs2304456, rs4291 and rs4343 (P>0.05). The differences between the genotype and allelotype distributions of the rs4309 were statistically significant (P<0.05). Haplotype analysis confirmed the existence of three haplotypes (AG, AT, GT) composed of rs710446/rs2304456, and six haplotypes (ATA, ACA, TCA, TCG, TTA, TTG) composed of rs4291/rs4309/rs4343, among which the distribution of ATA, ACA, TCA between the two groups was statistically significant difference (P<0.05). Our study showed that the polymorphisms of rs5516, rs710446, rs2304456, rs4291 and rs4343 is not related to the incidence of LOAD. The polymorphisms of rs4309 may be related to LOAD, as well as ATA, ACA, and TCA haplotype composed of rs4291/rs4309/rs4343.

Entities:  

Keywords:  Alzheimer’s disease; gene; kallikrein-kinin system; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26884824      PMCID: PMC4730037     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

Review 1.  [Vascular risk factors for Alzheimer's disease].

Authors:  O S Levin; N A Trusova
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2013

2.  KNG1 Ile581Thr and susceptibility to venous thrombosis.

Authors:  Pierre-Emmanuel Morange; Tiphaine Oudot-Mellakh; William Cohen; Marine Germain; Noémie Saut; Guillemette Antoni; Marie-Christine Alessi; Marion Bertrand; Anne-Marie Dupuy; Luc Letenneur; Mark Lathrop; Lorna M Lopez; Jean-Charles Lambert; Joseph Emmerich; Philippe Amouyel; David-Alexandre Trégouët
Journal:  Blood       Date:  2011-01-26       Impact factor: 22.113

3.  Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.

Authors:  Marguerite R Irvin; Amy I Lynch; Edmond K Kabagambe; Hemant K Tiwari; Joshua I Barzilay; John H Eckfeldt; Eric Boerwinkle; Barry R Davis; Charles E Ford; Donna K Arnett
Journal:  J Hypertens       Date:  2010-10       Impact factor: 4.844

4.  A genome-wide association study identifies KNG1 as a genetic determinant of plasma factor XI Level and activated partial thromboplastin time.

Authors:  Maria Sabater-Lleal; Angel Martinez-Perez; Alfonso Buil; Lasse Folkersen; Juan Carlos Souto; Maria Bruzelius; Montserrat Borrell; Jacob Odeberg; Angela Silveira; Per Eriksson; Laura Almasy; Anders Hamsten; José Manuel Soria
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-14       Impact factor: 8.311

5.  EFNS guidelines for the diagnosis and management of Alzheimer's disease.

Authors:  J Hort; J T O'Brien; G Gainotti; T Pirttila; B O Popescu; I Rektorova; S Sorbi; P Scheltens
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

6.  Association of PS1 1/2, ACE I/D, and LRP C/T polymorphisms with Alzheimer's disease in the Chinese population: a meta-analysis of case-control studies.

Authors:  L Yang; H-H Zhou; Y-F Ye; X-W Fan; Y-J Wang; Y Meng
Journal:  Genet Mol Res       Date:  2015-02-06

7.  Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes.

Authors:  Scott Miners; Emma Ashby; Shabnam Baig; Rachel Harrison; Hannah Tayler; Elizabeth Speedy; Jonathan A Prince; Seth Love; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2009-01-18       Impact factor: 4.060

8.  An age effect on the association of common variants of ACE with Alzheimer's disease.

Authors:  Nicole Helbecque; Valerie Codron; Dominique Cottel; Philippe Amouyel
Journal:  Neurosci Lett       Date:  2009-06-17       Impact factor: 3.046

9.  Gender-specific association between the kininogen 1 gene variants and essential hypertension in Chinese Han population.

Authors:  Weiyan Zhao; Yaping Wang; Laiyuan Wang; Xiangfeng Lu; Wei Yang; Jianfeng Huang; Shufeng Chen; Dongfeng Gu
Journal:  J Hypertens       Date:  2009-03       Impact factor: 4.844

Review 10.  Cardiovascular risk factors and future risk of Alzheimer's disease.

Authors:  Renée F A G de Bruijn; M Arfan Ikram
Journal:  BMC Med       Date:  2014-11-11       Impact factor: 8.775

View more
  2 in total

1.  Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.

Authors:  Xiao-Yu Xin; Ze-Hua Lai; Kai-Qi Ding; Li-Li Zeng; Jian-Fang Ma
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

Review 2.  A comprehensive systematic review of CSF proteins and peptides that define Alzheimer's disease.

Authors:  Juan R Peinado; Yoana Rabanal-Ruiz; Cristina M Pedrero-Prieto; Sonia García-Carpintero; Javier Frontiñán-Rubio; Emilio Llanos-González; Cristina Aguilera García; Francisco J Alcaín; Iris Lindberg; Mario Durán-Prado
Journal:  Clin Proteomics       Date:  2020-06-05       Impact factor: 3.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.